213 related articles for article (PubMed ID: 27290972)
1. Development of effective prophylaxis against intraoperative carcinoid crisis.
Woltering EA; Wright AE; Stevens MA; Wang YZ; Boudreaux JP; Mamikunian G; Riopelle JM; Kaye AD
J Clin Anesth; 2016 Aug; 32():189-93. PubMed ID: 27290972
[TBL] [Abstract][Full Text] [Related]
2. Octreotide LAR and bolus octreotide are insufficient for preventing intraoperative complications in carcinoid patients.
Massimino K; Harrskog O; Pommier S; Pommier R
J Surg Oncol; 2013 Jun; 107(8):842-6. PubMed ID: 23592524
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of Octreotide: Clinical Implications for Anesthesiologists and Associated Risks.
Borna RM; Jahr JS; Kmiecik S; Mancuso KF; Kaye AD
Anesthesiol Clin; 2017 Jun; 35(2):327-339. PubMed ID: 28526153
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
Condron ME; Pommier SJ; Pommier RF
Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
[TBL] [Abstract][Full Text] [Related]
5. Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management.
Claure RE; Drover DD; Haddow GR; Esquivel CO; Angst MS
Can J Anaesth; 2000 Apr; 47(4):334-7. PubMed ID: 10764178
[TBL] [Abstract][Full Text] [Related]
6. Partial hepatic resections for metastatic neuroendocrine tumors: perioperative outcomes.
Kinney MAO; Nagorney DM; Clark DF; O'Brien TD; Turner JD; Marienau ME; Schroeder DR; Martin DP
J Clin Anesth; 2018 Dec; 51():93-96. PubMed ID: 30098573
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Octreotide and Vasopressors as First-Line Treatment for Intraoperative Carcinoid Crisis.
McCully BH; Kozuma K; Pommier S; Pommier RF
Ann Surg Oncol; 2024 May; 31(5):2996-3002. PubMed ID: 38227166
[TBL] [Abstract][Full Text] [Related]
8. Anesthetic Management of Gastrointestinal Carcinoid Tumors: A Case Report.
Wiederholt B; Gengler T; Bendure J
AANA J; 2022 Oct; 90(5):377-382. PubMed ID: 36173796
[TBL] [Abstract][Full Text] [Related]
9. Octreotide treatment of carcinoid hypertensive crisis.
Warner RR; Mani S; Profeta J; Grunstein E
Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
[TBL] [Abstract][Full Text] [Related]
10. The prophylactic use of octreotide in a patient with ovarian carcinoid and valvular heart disease.
Watson JT; Badner NH; Ali MJ
Can J Anaesth; 1990 Oct; 37(7):798-800. PubMed ID: 2225298
[TBL] [Abstract][Full Text] [Related]
11. Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.
Castillo JG; Filsoufi F; Adams DH; Raikhelkar J; Zaku B; Fischer GW
Br J Anaesth; 2008 Nov; 101(5):618-26. PubMed ID: 18689806
[TBL] [Abstract][Full Text] [Related]
12. Uneventful spinal anesthesia for a patient with carcinoid syndrome managed with long-acting octreotide.
Orbach-Zinger S; Lombroso R; Eidelman LA
Can J Anaesth; 2002; 49(7):678-81. PubMed ID: 12193484
[TBL] [Abstract][Full Text] [Related]
13. Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours.
Kinney MA; Warner ME; Nagorney DM; Rubin J; Schroeder DR; Maxson PM; Warner MA
Br J Anaesth; 2001 Sep; 87(3):447-52. PubMed ID: 11517130
[TBL] [Abstract][Full Text] [Related]
14. Mega-dose intravenous octreotide for the treatment of carcinoid crisis: a systematic review.
Seymour N; Sawh SC
Can J Anaesth; 2013 May; 60(5):492-9. PubMed ID: 23328959
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the pathophysiology of carcinoid crisis.
Condron ME; Jameson NE; Limbach KE; Bingham AE; Sera VA; Anderson RB; Schenning KJ; Yockelson S; Harukuni I; Kahl EA; Dewey E; Pommier SJ; Pommier RF
Surgery; 2019 Jan; 165(1):158-165. PubMed ID: 30415870
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin analogues do not prevent carcinoid crisis.
Guo LJ; Tang CW
Asian Pac J Cancer Prev; 2014; 15(16):6679-83. PubMed ID: 25169508
[TBL] [Abstract][Full Text] [Related]
17. A case of acute respiratory distress syndrome responsive to methylene blue during a carcinoid crisis.
van Diepen S; Sobey A; Lewanczuk R; Singh G; Sidhu S; Zibdawi M; Mullen JC
Can J Anaesth; 2013 Nov; 60(11):1085-8. PubMed ID: 24037749
[TBL] [Abstract][Full Text] [Related]
18. [Update on the anesthetic management of patients with malignant carcinoid syndrome].
Rodríguez-Cosmen C; Trillo Urrutia L; Pacreu Terradas S; Comps Vicente O; Escolano Villén F
Rev Esp Anestesiol Reanim; 2005 May; 52(5):291-4. PubMed ID: 15968907
[TBL] [Abstract][Full Text] [Related]
19. Β-Adrenergic agonist administration is not associated with secondary carcinoid crisis in patients with carcinoid tumor.
Limbach KE; Condron ME; Bingham AE; Pommier SJ; Pommier RF
Am J Surg; 2019 May; 217(5):932-936. PubMed ID: 30635207
[TBL] [Abstract][Full Text] [Related]
20. [Asystole during surgery to manage small intestine cancer: are we dealing with anaphylaxis or carcinoid crisis].
Aissa I; Benakrout A; Meziane M; Bensghir M; Lalaoui SJ
Pan Afr Med J; 2018; 30():92. PubMed ID: 30344876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]